Paul Hastings Advises William Macklowe Co. in two New York Real Estate Transactions

Paul Hastings LLP, a leading global law firm, announced today that the firm represented William Macklowe Co. in the sale of two office buildings. William Macklowe has sold majority interests in 400 Madison to ASB Real Estate for $148 million and 610 Broadway to LaSalle Investment Management for $116 million. William Macklowe Co. retains 10% stakes in each property.

More >>

Tags:  Paul Hastings, LLP | New York

Polsinelli Shughart New York Adds Trio of Intellectual Property Litigators to Enhance Pharmaceutical Patent Practice

Citing a need to expand services to the pharmaceutical and medical device industries, Polsinelli Shughart welcomes three highly experienced intellectual property shareholders in New York. Tedd W. Van Buskirk, Dr. Pamela Fekete, and Dillon Kim bring more than 35 years combined experience in patent and trademark matters. The trio, who practiced together previously, focuses predominantly on patent litigation arising under the Hatch-Waxman Act and related regulatory, antitrust, and ANDA counseling work. Their clients include pharmaceutical, medical device, biotech, and other life sciences companies.

More >>

Tags:  Polsinelli PC | New York

Simpson Thacher Represents the Underwriters in $2.0 Billion Notes Offering by Bristol-Myers Squibb Company

The Firm represented the underwriters, led by Citigroup Global Markets Inc., Barclays Capital Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wells Fargo Securities, LLC, in connection with the public offering of $2.0 billion of debt securities of Bristol-Myers Squibb Company (“BMS”), consisting of $750,000,000 of 0.875% Notes due 2017, $750,000,000 of 2.000% Notes due 2022 and $500,000,000 of 3.250% Notes due 2042.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Simpson Thacher Represents Underwriters in $1 Billion Debt Offering by FedEx Corporation

The Firm recently represented the underwriters, led by Goldman, Sachs & Co. and J.P. Morgan Securities LLC, in connection with a public offering by FedEx Corporation of $500 million aggregate principal amount of 2.625% Notes due 2022 and $500 million aggregate principal amount of 3.875% Notes due 2042. The Notes are guaranteed by 10 subsidiaries of FedEx. The offering closed on July 27, 2012.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Simpson Thacher Represents Underwriters in $575 Million Initial Public Offering of Nuveen Preferred and Income Term Fund

Simpson Thacher represented the underwriters, led by Wells Fargo Securities, LLC, UBS Securities LLC and Nuveen Securities, LLC, in connection with the initial public offering of Nuveen Preferred and Income Term Fund (the “Fund”). The offering raised approximately $575 million, assuming full exercise of the underwriters’ option to purchase additional shares.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Paul Hastings Represents Grupo Petrotemex S.A. de C.V. in $275M Bond Buyback

Paul Hastings LLP, a leading global law firm, announced today that the firm is representing Grupo Petrotemex, S.A. de C.V., a Mexico-based leading petrochemical company specializing in the manufacturing of polyester-related raw materials, in connection with the successful cash tender offer for $275 million, and consent solicitation to amend the provisions, of Petrotemex’s 9.5% Senior Notes due 2014, issued in 2009.

More >>

Tags:  Paul Hastings, LLP | New York

Cravath – Unilever’s Sale of North American Frozen Meals Business to ConAgra Foods

On July 30, 2012, Unilever announced that it has signed a definitive agreement for the sale of its North American frozen meals business to ConAgra Foods, Inc. for a total cash consideration of $265 million. Cravath represented Unilever in connection with this transaction. Unilever’s North American frozen meals business consists of a full range of premium, multi-serve frozen entrees and appetizers under the well-known Bertolli and P.F. Chang’s brand names. The transaction is subject to regulatory review and expected to close in the third quarter of 2012.

More >>

Tags:  Cravath, Swaine & Moore LLP | New York